Periodontal treatment increases quality of life outcomes in Type 1 and Type 2 diabetic patients with periodontitis: the randomized-controlled trial DIAPERIO

2018 ◽  
Author(s):  
Thibault Canceill
Keyword(s):  
Quality Of Life ◽  
Controlled Trial ◽  
Diabetic Patients ◽  
Life Outcomes ◽  
Type 2 Diabetic Patients ◽  
Randomized Controlled ◽  
Type 2 Diabetic

scholarly journals Web-Based Depression Treatment for Type 1 and Type 2 Diabetic Patients: A randomized, controlled trial

Diabetes Care ◽  
2011 ◽  
Vol 34 (2) ◽  
pp. 320-325 ◽  
Author(s):  
K. M. P. van Bastelaar ◽  
F. Pouwer ◽  
P. Cuijpers ◽  
H. Riper ◽  
F. J. Snoek
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Diabetic Patients ◽  
Depression Treatment ◽  
Type 2 Diabetic Patients ◽  
Web Based ◽  
Randomized Controlled ◽  
Type 2 Diabetic

Painful diabetic polyneuropathy and quality of life in Danish type 2 diabetic patients

2017 ◽  
Vol 16 (1) ◽  
pp. 173-173 ◽  
Author(s):  
Sandra Sif Gylfadottir ◽  
Diana Hedevang Christensen ◽  
Sia Kromann Nicolaisen ◽  
Reimar Wernich Thomsen ◽  
Jens Steen Nielsen ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Pain Intensity ◽  
Rating Scale ◽  
Diabetic Polyneuropathy ◽  
Numeric Rating Scale ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

Abstract Background and aims Painful polyneuropathy (PPN) is a disabling complication of diabetes. This study aims to determine its prevalence and relationship with Quality of Life (QoL) in a nationwide prospective cohort of incident recently diagnosed Danish type 2 diabetic patients. Methods We sent a detailed questionnaire on neuropathy, pain and QoL to 6726 patients prospectively enrolled from general practitioners and hospital specialist outpatient clinics into the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort. Patients who reported pain in both feet and a score ≥3 on the Douleur Neuropathique (DN4) questionnaire were considered to have possible PPN. QoL and pain intensity were measured on a numeric rating scale (NRS, 0–10). The Michigan Neuropathy Screening Instrument (MNSI) was used to assess neuropathy. Results A total of 5371 (79.8%) returned a complete questionnaire. 848 (15.8%) recently diagnosed type 2 diabetic patients reported pain in both feet. Of the 619 patients with pain who completed the DN4 questionnaire, 404 (65.2%) had a DN4 score ≥ 3, corresponding to a prevalence in the total population of possible PPN of 10.3%. Mean pain intensity was 5.2 (SD 2.2) and 89% had a MNSI score ≥ 3. Patients with possible PPN had a substantially lower QoL score than those without PPN (median QoL score 6 versus 8 (p < 0.001)), also when correcting for MNSI score. Conclusions Ten percent of newly diagnosed type 2 diabetic patients in Denmark had possible PPN. Patients with PPN had lower QoL than patients without PPN.

scholarly journals A cross-sectional assessment of health-related quality of life among type 2 diabetic patients in Pakistan

2016 ◽  
Vol 8 (1) ◽  
pp. 64 ◽  
Author(s):  
Fahad Saleem ◽  
Saeedur Rashid Nazir ◽  
MohamedAzmi Hassali ◽  
Sajid Bashir ◽  
Furqan Hashmi ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Diabetic Patients ◽  
Health Related Quality ◽  
Type 2 Diabetic Patients ◽  
Cross Sectional ◽  
Related Quality ◽  
Health Related ◽  
Type 2 Diabetic

Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: a randomized controlled trial.

2021 ◽  
pp. 101280
Author(s):  
Vicente Hidalgo Rodrigues Fernandes ◽  
Fernando R.P. Chaves ◽  
Alexandre A.S. Soares ◽  
Ikaro Breder ◽  
Sheila T. Kimura-Medorima ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Retinal Thickness ◽  
Controlled Trial ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Randomized Controlled ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document